SM
BNTCW

Sabby Management’s Benitec Biopharma Limited BNTCW Stock Holding History

Sabby Management’s Portfolio BNTCW Stock Details BNTCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-87,693
Closed -$21K – 201
2018
Q1 		$21K Buy
+87,693
New +$31.1K ﹤0.01% 148

Other funds holding BNTCW

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Sabby Management's BNTCW Position: Q4 2019 in Review

Sabby Management sold out of Benitec Biopharma Limited (BNTCW) in Q4 2019, closing a stake of 51,449 shares — an estimated $1K sold.

Sabby Management first reported a position in BNTCW in Q4 2016 and held it in 11 quarters. The position peaked at $37K in Q1 2017. 1 fund tracked by Wall St. Rank holds BNTCW as of Q4 2019.

  • Sabby Management reported no remaining Benitec Biopharma Limited position as of Q4 2019 after selling out during the quarter.
  • Sabby Management sold 51,449 Benitec Biopharma Limited shares in Q4 2019, an estimated $1K.
  • Sabby Management first reported a position in Benitec Biopharma Limited in Q4 2016 and held it in 11 quarters.
  • Sabby Management's Benitec Biopharma Limited position peaked at $37K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Benitec Biopharma Limited as of Q4 2019.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.